BioPharma Credit PLC (LON:BPCP)

Market Cap	805.77M +11.4%
Revenue (ttm)	117.21M +5.1%
Net Income	96.51M +6.3%
EPS	0.08 +14.0%
Shares Out	n/a
PE Ratio	8.35
Forward PE	n/a
Dividend	0.07 (10.22%)
Ex-Dividend Date	Jul 2, 2026

Volume	134,842
Open	72.13
Previous Close	72.30
Day's Range	71.71 - 72.13
52-Week Range	63.68 - 74.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

• Industry: Asset Management
• Sector: Financials
• Founded: 2016
• Country: United Kingdom
• Stock Exchange: London Stock Exchange
• Ticker Symbol: BPCP

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 12, 2026

Data Sources Report a data error